1. Home
  2. ITP vs GOVX Comparison

ITP vs GOVX Comparison

Compare ITP & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IT Tech Packaging Inc.

ITP

IT Tech Packaging Inc.

HOLD

Current Price

$0.19

Market Cap

4.0M

ML Signal

HOLD

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

HOLD

Current Price

$1.60

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITP
GOVX
Founded
1996
2001
Country
China
United States
Employees
N/A
17
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
4.0M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ITP
GOVX
Price
$0.19
$1.60
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
3.3M
406.1K
Earning Date
05-12-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
1.01
N/A
EPS
N/A
N/A
Revenue
$75,837,943.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$0.12
52 Week High
$0.39
$4.40

Technical Indicators

Market Signals
Indicator
ITP
GOVX
Relative Strength Index (RSI) 48.62 64.43
Support Level $0.18 $1.41
Resistance Level $0.20 $4.40
Average True Range (ATR) 0.01 0.18
MACD -0.00 0.08
Stochastic Oscillator 51.43 65.31

Price Performance

Historical Comparison
ITP
GOVX

About ITP IT Tech Packaging Inc.

IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It is involved in the production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments: Dongfang Paper and Tengsheng Paper, which produce offset printing paper, corrugating medium paper, and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Share on Social Networks: